✦ LIBER ✦

Safety and Efficacy of Stereotactic Radiosurgery and Adjuvant Bevacizumab in Patients With Recurrent Malignant Gliomas

✍ Scribed by Kyle C. Cuneo; James J. Vredenburgh; John H. Sampson; David A. Reardon; Annick Desjardins; Katherine B. Peters; Henry S. Friedman; Christopher G. Willett; John P. Kirkpatrick

Book ID: 118455494
Publisher: Elsevier Science
Year: 2012
Tongue: English
Weight: 295 KB
Volume: 82
Category: Article
ISSN: 0360-3016
DOI: 10.1016/j.ijrobp.2010.12.074

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Concurrent Stereotactic Radiosurgery and

Concurrent Stereotactic Radiosurgery and Bevacizumab in Recurrent Malignant Gliomas: A Prospective Trial

✍ Cabrera, Alvin R.; Cuneo, Kyle C.; Desjardins, Annick; Sampson, John H.; McSherr 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 867 KB

Bevacizumab in Patients Treated with Ste

Bevacizumab in Patients Treated with Stereotactic Radiosurgery for Recurrent Malignant Gliomas is Associated with Improved Overall Survival

✍ K.C. Cuneo; J.J. Vredenburgh; J.H. Sampson; D.A. Reardon; A. Desjardins; C.G. Wi 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 58 KB

Efficacy of stereotactic radiosurgery as

Efficacy of stereotactic radiosurgery as a salvage treatment for recurrent malignant gliomas

✍ Doo-Sik Kong; Jung-Il Lee; Kwan Park; Jong Hyun Kim; Do-Hoon Lim; Do-Hyun Nam 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 131 KB

## Abstract ## BACKGROUND The objective of this prospective cohort study was to determine the efficacy of stereotactic radiosurgery (SRS) as a salvage treatment in patients with recurrent malignant gliomas. ## METHODS Between January 2000 and December 2006, 114 consecutive patients were treated

Efficacy, safety and patterns of respons

Efficacy, safety and patterns of response and recurrence in patients with recurrent high-grade gliomas treated with bevacizumab plus irinotecan

✍ R. M. Zuniga; R. Torcuator; R. Jain; J. Anderson; T. Doyle; S. Ellika; L. Schult 📂 Article 📅 2008 🏛 Springer US 🌐 English ⚖ 452 KB

8702 ORAL A Phase II, Multicenter, Clini

8702 ORAL A Phase II, Multicenter, Clinical Trial to Evaluate the Efficacy and Safety of Bevacizumab Alone in Japanese Patients With Recurrent Malignant Glioma

✍ Matsutani, M.; Nishikawa, R.; Kobayashi, H.; Takano, S.; Shinoura, N.; Nagane, M 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 41 KB

Hypofractionated stereotactic radiothera

Hypofractionated stereotactic radiotherapy and continuous low-dose temozolomide in patients with recurrent or progressive malignant gliomas

✍ Giuseppe Minniti, Claudia Scaringi, Vitaliana De Sanctis, Gaetano Lanzetta, Tere 📂 Article 📅 2012 🏛 Springer US 🌐 English ⚖ 227 KB